During the past decade, Helen and Harry Gray Cancer Center at Hartford Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 17 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helen and Harry Gray Cancer Center at Hartford Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 9 trials, followed by "NSABP Foundation Inc" with 7 trials sponsored, "Gynecologic Oncology Group" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Northwestern University" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helen and Harry Gray Cancer Center at Hartford Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Helen and Harry Gray Cancer Center at Hartford Hospital" are "Breast Cancer" (8 trials), "Lung Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Leukemia" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Helen and Harry Gray Cancer Center at Hartford Hospital" in a lesser frequency.

Most popular intervention types in "Helen and Harry Gray Cancer Center at Hartford Hospital" are "Drug" (22 trials), "Other" (8 trials), "Biological" (6 trials), "Radiation" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "placebo" (5 trials), "docetaxel" (4 trials), "gemcitabine hydrochloride" (3 trials) and "paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Helen and Harry Gray Cancer Center at Hartford Hospital" are 14 trials for "Female" genders, 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Helen and Harry Gray Cancer Center at Hartford Hospital". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Helen and Harry Gray Cancer Center at Hartford Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Helen and Harry Gray Cancer Center at Hartford Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".